SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-010230
Filing Date
2021-05-14
Accepted
2021-05-14 08:09:43
Documents
2
Period of Report
2021-05-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nltxmayagm8-kform.htm 8-K 36190
2 EX-10.1 ex-101amendedandrestated20.htm EX-10.1 268939
  Complete submission text file 0001628280-21-010230.txt   306471
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 21922001
SIC: 2834 Pharmaceutical Preparations